APO-GEMFIBROZIL 600 MG
GEMFIBROZIL : 600 MG · DIN 01979582 · APOTEX INC
Health Canada status: CANCELLED POST MARKET
What is APO-GEMFIBROZIL?
APO-GEMFIBROZIL 600 MG contains GEMFIBROZIL : 600 MG. It is listed in the Health Canada Drug Product Database under DIN 01979582, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-GEMFIBROZIL used for?
APO-GEMFIBROZIL (gemfibrozil) is indicated as an adjunct to diet and other therapeutic measures for: 1. Treatment of adult patients with very high serum triglyceride levels, Fredrickson classification Type IV and V hyperlipidemias, who are at a high risk of sequelae and complications (i.e. pancreatitis) from their hyperlipidemia. 2. Treatment of patients with hypercholesterolemia, Type Ila and lIb mixed dyslipidemias, to regulate lipid levels (reduce serum triglycerides and LDL cholesterol levels and increase HDL cholesterol).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01979582 |
|---|---|
| Brand name | APO-GEMFIBROZIL |
| Generic / active ingredient | GEMFIBROZIL : 600 MG |
| Manufacturer | APOTEX INC |
| Strength | 600 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AB04 GEMFIBROZIL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Jul-2024 |
| Original market date | 1984-12-31 00:00:00 |
How is it stored and handled?
Capsules: Store at room temperature 15-30 °C (59-86 °F). Tablets: Store between 15-25 °C (59-77 °F). Protect from moisture.
How is it supplied?
Capsules 300 mg: bottles of 100 and 500. Tablets 600 mg: bottles of 100 and 500 and in unit dose packages of 100.
What can be used instead?
Other Canadian products sharing ATC code C10AB04 GEMFIBROZIL. 1 of 22 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-GEMFIBROZIL | 600 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02142074 |
| APO-GEMFIBROZIL CAP 300MG USP | 300 MG | CAPSULE | APOTEX INC | CANCELLED POST MARKET | DIN 01979574 |
| DOM-GEMFIBROZIL | 300 MG | CAPSULE | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02241608 |
| DOM-GEMFIBROZIL | 600 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02230580 |
| GEMFIBROZIL CAP 300MG | 300 MG | CAPSULE | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 00851922 |
| GEMFIBROZIL TAB 600MG | 600 MG | TABLET | OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | DIN 00851930 |
| GEMFIBROZIL-300 - CAP | 300 MG | CAPSULE | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02136031 |
| GEMFIBROZIL-600 - TAB 600MG | 600 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02136058 |
| LOPID 600MG | 600 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00659606 |
| LOPID CAP 300MG | 300 MG | CAPSULE | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00599026 |
Who else supplies GEMFIBROZIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. GEMFIBROZIL appears in 24 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.